Diagnostic agent for angiopathic diseases
AssigneeYamasa Corporation
InventorsTsutomu Iwasaki, Ryozo Nagai, Hirohisa Katoh
Life of this patent
Estimating the term…
Abstract
A diagnostic agent for angiopathic diseases containing a monoclonal antibody against human smooth muscle myosin or active fragments of the antibody labeled with a radioactive isotope; a kit thereof; and a method of diagnostic imaging for angiopathic diseases by using the same. The invention permits the diagnostic imaging of angiopathic diseases such as dissecting aortic aneurysm and angiitis and the specification of the region affected by these diseases.
Claims6
A method of diagnostic imaging and determining the pathological site of dissecting aortic aneurysm comprising:
- administering a diagnostic agent to a patient, said diagnostic agent comprising a monoclonal antibody against human smooth muscle myosin, or active fragments thereof, labeled with a radioactive isotope, said antibody being (1) reactive with smooth muscle myosin heavy chains and not with smooth muscle myosin light chains, (2) reactive with smooth muscle myosin and not with skeletal muscle myosin, heart muscle myosin, or platelet myosin, and (3) reactive with both human smooth muscle myosin and rat smooth muscle myosin, and
- measuring radioactivity in the patient after administration and imaging the pathological site of dissecting aortic aneurysm in the patient.
A method of diagnostic imaging and determining the pathological site of angiitis comprising:
- administering a diagnostic agent to a patient, said diagnostic agent comprising a monoclonal antibody against human smooth muscle myosin, or active fragments thereof, labeled with a radioactive isotope, said antibody being (1) reactive with smooth muscle myosin heavy chains and not with smooth muscle myosin light chains, (2) reactive with smooth muscle myosin and not with skeletal muscle myosin, heart muscle myosin, or platelet myosin, and (3) reactive with both human smooth muscle myosin and rat smooth muscle myosin, and
- measuring radioactivity in the patient after administration and imaging the pathological site of angiitis in the patient.
Dependencies are inferred from the claim text.